Ifigeneia Tzannou

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting”.

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2415

N/A

2.1DataRank · unranked

82 citations

Ifigeneia Tzannou, Meng-Fen Wu, Carlos A. Ramos, Ghadir Sasa, Caridad Martinez +14 more

Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies

Frontiers in Immunology(2022)10.3389/fimmu.2022.899972

N/A

0.449DataRank · unranked

19 citations

Maria Pagoni, Margherita Rosati, Matthew Angel, Ifigeneia Tzannou, Margarita Vlachou +12 more

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

Science Translational Medicine(2020)10.1126/scitranslmed.aaz3339

N/A

0DataRank · unranked

40 citations

Ifigeneia Tzannou, Spyridoula Vasileiou, George Carrum, Carlos A. Ramos, Rammurti T. Kamble +19 more